ENDRA LIFE SCIENCES INC. (NDRA) Gross Margin
- Gross margin · 12 months: Value (m); Formula and calculation Gross profit / revenue. Period ending 2020-12-31..
Gross margin
Overview →Financial period ending 2020-12-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | (m) | Gross profit / revenue. Period ending 2020-12-31. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 0.00 USD | Gross Profit |
| Revenue | 0.00 USD | |
| Cost of products and services | (m) | Cost of Goods and Services Sold |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2020-12-31 | $0.00 | $0.00 | (m) | (m) |
| 2019-12-31 | $0.00 | $0.00 | (m) | (m) |
| 2019-09-30 | $0.00 | $0.00 | (m) | (m) |
| 2019-06-30 | $0.00 | $0.00 | (m) | (m) |
| 2019-03-31 | $0.00 | $0.00 | (m) | (m) |
| 2018-12-31 | $6.17K | $6.17K | (m) | 100.00% |
| 2018-09-30 | $9.94K | $13.02K | (m) | 76.31% |
| 2018-06-30 | $178.67K | $300.02K | (m) | 59.55% |
| 2018-03-31 | $185.01K | $357.80K | (m) | 51.71% |
| 2017-12-31 | $178.84K | $351.62K | (m) | 50.86% |
| 2017-09-30 | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | (m) | (m) | (m) |
| 2016-12-31 | $279.70K | $515.58K | (m) | 54.25% |
| 2016-09-30 | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |